Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2
- PMID: 16825431
- PMCID: PMC2597904
- DOI: 10.1136/jmg.2006.043257
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2
Abstract
Patients with biallelic mutations in BRCA2 are in Fanconi anaemia group D1. We analysed the severity of the mutations in 27 cases, classified according to their association with breast cancer in heterozygotes, and their predicted functional effect. Twenty mutations were frameshifts or truncations, three involved splice sites, five were missense variants of unknown severity and two were benign polymorphisms. Five patients had VACTERL-H association. Leukaemia was reported in 13 patients, and solid tumours in 15; 6 patients had two or more malignancies. The cumulative probability of any malignancy was 97% by age 5.2 years. IVS7+1G-->A and IVS7+2T-->G were associated with AML, and 886delGT and 6174delT with brain tumours. However, patients with other alleles remained at very high risk of these events. Missense mutations formed a distinct cluster in a highly conserved region of the BRCA2 protein. The small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, and early onset and high rates of leukaemia and specific solid tumours, and may comprise an extreme variant of Fanconi anaemia. Several of the alleles were not associated with cancer in presumed carriers, and thus counselling presents more uncertainties than usual.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.Pediatr Blood Cancer. 2012 Mar;58(3):462-5. doi: 10.1002/pbc.23168. Epub 2011 May 5. Pediatr Blood Cancer. 2012. PMID: 21548014
-
Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.Eur J Hum Genet. 2014 Aug;22(8):979-87. doi: 10.1038/ejhg.2013.278. Epub 2013 Dec 4. Eur J Hum Genet. 2014. PMID: 24301060 Free PMC article. Review.
-
Biallelic inactivation of BRCA2 in Fanconi anemia.Science. 2002 Jul 26;297(5581):606-9. doi: 10.1126/science.1073834. Epub 2002 Jun 13. Science. 2002. PMID: 12065746
-
Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.Fam Cancer. 2017 Jul;16(3):441-446. doi: 10.1007/s10689-017-9968-y. Fam Cancer. 2017. PMID: 28185119
-
Fanconi Anaemia, Childhood Cancer and the BRCA Genes.Genes (Basel). 2021 Sep 27;12(10):1520. doi: 10.3390/genes12101520. Genes (Basel). 2021. PMID: 34680915 Free PMC article. Review.
Cited by
-
Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility.PLoS Genet. 2018 Dec 12;14(12):e1007821. doi: 10.1371/journal.pgen.1007821. eCollection 2018 Dec. PLoS Genet. 2018. PMID: 30540754 Free PMC article.
-
Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish.PLoS Genet. 2011 Mar;7(3):e1001357. doi: 10.1371/journal.pgen.1001357. Epub 2011 Mar 31. PLoS Genet. 2011. PMID: 21483806 Free PMC article.
-
BRCA2 and TP53 collaborate in tumorigenesis in zebrafish.PLoS One. 2014 Jan 29;9(1):e87177. doi: 10.1371/journal.pone.0087177. eCollection 2014. PLoS One. 2014. PMID: 24489863 Free PMC article.
-
DNA crosslinking damage and cancer - a tale of friend and foe.Transl Cancer Res. 2013 Jun;2(3):144-154. doi: 10.3978/j.issn.2218-676X.2013.03.01. Transl Cancer Res. 2013. PMID: 23998004 Free PMC article.
-
Genetic counseling for Fanconi anemia: crosslinking disciplines.J Genet Couns. 2014 Dec;23(6):910-21. doi: 10.1007/s10897-014-9754-z. Epub 2014 Sep 20. J Genet Couns. 2014. PMID: 25236480 Review.
References
-
- Alter B P. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Nathan and Oski's Hematology of Infancy and Childhood, 6th edn. Philadelphia, PA: WB Saunders, 2003280–365.
-
- Taniguchi T, D'Andrea A D. The molecular pathogenesis of Fanconi anemia: recent progress. Blood 20061074223–4233. - PubMed
-
- Kennedy R D, D'Andrea A D. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev 2005192925–2940. - PubMed
-
- Ford D, Easton D F, Stratton M, Narod S, Goldgar D, Devilee P, Bishop D T, Weber B, Lenoir G, Chang‐Claude J, Sobol H, Teare M D, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck T R, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder B A, Gayther S A, Zelada‐Hedman M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 199862676–689. - PMC - PubMed
-
- The Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999911310–1316. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous